Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 28 Jun 2024

Active monitoring of antifungal adverse events in hospitalized patients based on Global Trigger Tool method

in Pharmacoepidemiology

Xiao Meng
Yaozhou Wu
Zixuan Liu
Yifan Chen
Zhizhou Dou
Li Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1322587

1,029 views
1 citation

Original Research

Published on 27 Jun 2024

Delabelling beta-lactam allergy

in Pharmacoepidemiology

Gustavo-Jorge Molina-Molina
Diana Rocío Garnica Velandia
Blanca Andrés-López
Carolina Perales
Laura Marin-Asensio
Yanina Jurgens
Olga Esteso
Carolina Escobar
Xavier Vidal
Lourdes Vendrell

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1423719

2,405 views

Original Research

Published on 26 Jun 2024

Statin use and fall risk in adults: a cross-sectional survey and mendelian randomization analysis

in Pharmacoepidemiology

Hui Zheng
Yong-Jiang Fang
Shu-Ting Wang
Yan-Bing Huang
Tai-Chun Tang
Min Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364733

4,845 views
2 citations

Original Research

Published on 24 Jun 2024

Pulmonary haemorrhage and haemoptysis associated with bevacizumab-related treatment regimens: a retrospective, pharmacovigilance study using the FAERS database

in Pharmacoepidemiology

Huiping Hu
Zhiwen Fu
Jinmei Liu
Cong Zhang
Shijun Li
Yu Zhang
Ruxu You

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1339505

2,085 views
2 citations

Original Research

Published on 20 Jun 2024

Effect of ultrashort-acting β-blockers on 28-day mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a meta-analysis of randomized controlled trials and trial sequential analysis

in Pharmacoepidemiology

Po Huang
Fusheng Liu
Xiao Hu
Bo Li
Xiaolong Xu
Qingquan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1380175

1,834 views
1 citation

Original Research

Published on 20 Jun 2024

Consumer awareness and knowledge regarding use of non-steroidal anti-inflammatory drugs (NSAIDs) in a metropolitan area

in Pharmacoepidemiology

Paolo Montuori
Seyedeh Zahra Shojaeian
Francesca Pennino
Daniela D’Angelo
Michele Sorrentino
Salvatore Di Sarno
Raffaele Nubi
Alfonso Nardo
Maria Triassi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1362632

3,752 views
1 citation

Original Research

Published on 14 Jun 2024

Hepatitis-related adverse events associated with immune checkpoint inhibitors in cancer patients: an observational, retrospective, pharmacovigilance study using the FAERS database

in Pharmacoepidemiology

Zhiwen Fu
Jinmei Liu
Cong Zhang
Huiping Hu
Shijun Li
Yu Zhang
Ruxu You

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1383212

2,789 views
4 citations

Original Research

Published on 14 Jun 2024

Risk of immune system and skin and subcutaneous tissue related adverse events associated with oxaliplatin combined with immune checkpoint inhibitors: a pharmacovigilance study

in Pharmacoepidemiology

Chunhong Zhang
Furong Li
Ying Dai
Yifan Zeng
Xuben Yu
Dawei Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1309540

1,439 views

Systematic Review

Published on 12 Jun 2024

An overview and single-arm meta-analysis of immune-mediated adverse events following COVID-19 vaccination

in Pharmacoepidemiology

Donghua Yang
Jinhui Tian
Caiyi Shen
Qin Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1308768

2,974 views

Original Research

Published on 12 Jun 2024

The prevalence of polypharmacy and hyper-polypharmacy among middle-aged vs. older patients in Saudi Arabia: a cross-sectional study

in Pharmacoepidemiology

Aymen A. Alqurain
Murtada Albaharnah
Samanah Al Zayer
Luma Ameer
Sherihan Ghosn
Samaher Al-Shaibi
Marwa Algoraini
Amal Aldhafeeri
Danah A. Alyusuf
Afnan Alshnbari

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1357171

2,884 views
3 citations

Original Research

Published on 12 Jun 2024

Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort

in Pharmacoepidemiology

Nathan Vidal
Paul Roux
Mathieu Urbach
Cristobal Belmonte
Laurent Boyer
Delphine Capdevielle
Julie Clauss-Kobayashi
Thierry D’Amato
Romane Dassing
Caroline Dubertret

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403093

1,730 views
1 citation

Original Research

Published on 07 Jun 2024

A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database

in Pharmacoepidemiology

Liyuan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397029

8,384 views
5 citations

Data Report

Published on 06 Jun 2024

The last 3 decade of vaccination coverage in the Balkan and Eastern Europe countries with reference to the impact of the COVID-19 pandemic

in Pharmacoepidemiology

Milos Stepovic
Viktorija Dragojevic Simic
Ivana Zivanovic Macuzic
Radoje Simic
Stefan Vekic
Marija Sekulic
Snezana Radovanovic
Milena Maricic
Marija Sorak
Vesna Suljagic

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1278771

5,256 views
2 citations

Original Research

Published on 05 Jun 2024

Comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events—a real-world longitudinal inception cohort study

in Pharmacoepidemiology

Xuechun Li
Maarten J. Bijlsma
Stijn de Vos
Jens H. J. Bos
Sumaira Mubarik
Catharina C. M. Schuiling-Veninga
Eelko Hak

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1357567

1,699 views
1 citation

Original Research

Published on 05 Jun 2024

Post-marketing safety of lorlatinib: a real-world study based on the FDA adverse event reporting system

in Pharmacoepidemiology

Huqun Li
Chongshu Wang
Cuilian Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1385036

4,386 views
3 citations

Original Research

Published on 31 May 2024

Risk of dyslipidemia and major adverse cardiac events with tofacitinib versus adalimumab in rheumatoid arthritis: a real-world cohort study from 7580 patients

in Pharmacoepidemiology

Xiao-Na Ma
Mei-Feng Shi
Shiow-Ing Wang
Wei Feng
Shu-Lin Chen
Xiao-Qin Zhong
Qing-Ping Liu
James Cheng-Chung Wei
Chang-Song Lin
Qiang Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1370661

2,712 views
5 citations